259 results
Page 2 of 13
8-K
EX-99.1
6qm8ac0t80l
29 Mar 21
Windtree Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Key Business Updates
5:26pm
424B5
bykzhv7r5jgd23urjr1n
24 Mar 21
Prospectus supplement for primary offering
5:14pm
424B5
npygu
22 Mar 21
Prospectus supplement for primary offering
4:39pm
8-K
EX-99.1
tb7vog
16 Nov 20
Windtree Therapeutics Reports Third Quarter 2020
7:40am
8-K
EX-99.1
1vb56 of6uud40f3c
1 Oct 20
Windtree Announces First Patient Dosed in Phase 2 Study of Istaroxime for the Acute Treatment of Early Cardiogenic Shock in Heart Failure Patients
7:36am
8-K
mfs6u0yg5
29 Sep 20
Other Events
7:37am
8-K
EX-99.1
355yt
29 Sep 20
Other Events
7:37am
8-K
EX-99.1
19amv khas11
14 Aug 20
Windtree Therapeutics Reports Second Quarter 2020 Financial Results and Provides Key Business Updates
6:07am
8-K
EX-99.2
if1y9ow
22 May 20
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:22pm
8-K
EX-99.1
6cxqnxo7t
22 May 20
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:22pm
424B4
akbr0a
21 May 20
Prospectus supplement with pricing info
6:04am